Evidence map›Paper›PMID 28196954›Full record

ReviewThe Journal of endocrinology2017

Metformin and thyroid disease.

Xianghui Meng, Shuhang Xu, Guofang Chen, Michael Derwahl, Chao Liu

Registry-linked trialOpen access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of endocrinology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04298684 (Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04298684 phase4unknown statusstarted 2021, after this paper: background citation

Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules Size in Type 2 Diabetes: a 2-years Prospective Multicentric Study

Ran2021Enrolled90Registered outcomes9Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Thyroid Nodule (Benign)ArmsMetformin, Sitagliptin
Open the trial in the graph
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Thyroid Nodules: Emerging Trends in Detection and Visualization based on Citespace.Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Effect of metformin onThe British journal of radiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Xianghui MengChinese Medicine Hospital in Linyi CityLinyi, China.
Shuhang XuAffiliated Hospital of Integrated Traditional Chinese and Western MedicineNanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Guofang ChenAffiliated Hospital of Integrated Traditional Chinese and Western MedicineNanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Michael DerwahlDivision of EndocrinologyDepartment of Medicine, St. Hedwig Hospital, Berlin, Germany.
Chao LiuAffiliated Hospital of Integrated Traditional Chinese and Western MedicineNanjing University of Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China liuchao@nfmcn.com.
Nanjing University of Chinese Medicine · CNLinyi People's Hospital · CNSt. Hedwig-Krankenhaus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An intriguing area of research in thyroidology is the recently discovered association of insulin resistance with thyroid functional and morphological abnormalities. Individuals with hyperinsulinemia have larger thyroid gland and a higher prevalence of thyroid nodules and cancer. Accordingly, patients treated with metformin have a smaller thyroid volume and a lower risk of incident goiter, thyroid nodule and cancer. Multiple studies

Indexed as

HumansHypoglycemic AgentsMetforminPituitary GlandThyroid DiseasesThyroid HormonesThyrotropinHypoglycemic AgentsMetforminThyroid HormonesThyrotropinmetforminthyroid cancerthyroid diseasethyroid nodulethyrotropin

Identifiers

PMID28196954
OpenAlexW2587863998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.